Form 4: Anita Pramoda Receives 20,807 RSUs from Health Catalyst, Inc.

Director Anita Pramoda acquired 20,807 Restricted Stock Units (RSUs) from Health Catalyst, Inc. on June 13, 2024, according to a Form 4 filing.

Summary

• Anita Pramoda, a director of Health Catalyst, Inc., received 20,807 Restricted Stock Units (RSUs) on June 13, 2024.
• The RSUs were granted pursuant to the company's 2019 Plan.
• Each RSU represents a contingent right to receive one share of Health Catalyst's common stock.
• The RSUs will fully vest on the earlier of (i) the one-year anniversary of the grant date or (ii) the date of the next Annual Meeting of the Issuer's Stockholders.
• Following the transaction, Ms. Pramoda beneficially owns 54,080 shares of common stock.

Sentiment

Score: 7

Explanation: The document is a routine regulatory filing indicating standard compensation practices. It doesn't contain information that would significantly sway investor sentiment positively or negatively.

Positives

• The grant of RSUs aligns the director's interests with those of the shareholders.
• The vesting schedule encourages long-term commitment from the director.

Future Outlook

The document does not contain any specific forward-looking statements regarding the company's future performance.

Industry Context

This is a standard disclosure related to executive compensation and is common in the healthcare technology industry.

Stakeholder Impact

• The RSU grant may have a minor positive impact on shareholder sentiment as it aligns director incentives with company performance.

Key Dates